CJ Lyon, WA Hsueh - The American journal of medicine, 2003 - Elsevier Concentrations of plasminogen activator inhibitor–1 (PAI-1) are elevated
beginning at the stage of impaired glucose tolerance and continuing through the
development of diabetes mellitus and the metabolic syndrome. Evolving ... Cited by 73 - Related articles - All 8 versions
RMA Henry, I Ferreira, PJ Kostense, JM … - Atherosclerosis, 2004 - Elsevier Background: Type 2 diabetes (DM2) and impaired glucose metabolism (IGM) are
associated with an increased cardiovascular disease risk. Impaired endothelial
synthesis of nitric oxide (NO) is an important feature of atherothrombosis ... Cited by 51 - Related articles - All 9 versions
- ►pasteur.ac.ir [PDF] M Nieuwdorp, ESG Stroes, JCM Meijers, H … - Current Opinion in Pharmacology, 2005 - Elsevier The metabolic syndrome is characterized by a combination of obesity, chronic
inflammation and insulin resistance. This syndrome also has features of a
hypercoagulable state, consisting of increased levels of clotting factors ( ... Cited by 47 - Related articles - All 4 versions
BA Lwaleed, PS Bass - Journal of Pathology, 2006 - eprints.soton.ac.uk Tissue factor (TF)-initiated coagulation plays a significant role in the
pathophysiology of many diseases, including cancer and inflammation. Tissue
factor pathway inhibitor (TFPI) is a plasma Kunitz-type serine protease ... Cited by 44 - Related articles - Cached - BL Direct - All 5 versions
AM Kanaya, W Fyr… - Archives of Internal Medicine, 2006 - Am Med Assoc Methods We analyzed the relationships among adiposity, adipocytokines, glycemia,
and incident diabetes mellitus in 2356 white and black adults aged 70 to 79
years in the Health, Aging, and Body Composition Study who did not have ... Cited by 39 - Related articles - All 4 versions
- ►nih.gov M Chakir, GE Plante - Prostaglandins, Leukotrienes & Essential Fatty Acids, 1996 - Elsevier In the present study, we examined the pattern of Evan's blue (EB) extravasation
over time and we verified the effect of two inhibitors of aldose reductase
(sorbinil and ARI 509) as well as aminoguanidine, which modulate nitric ... Cited by 34 - Related articles - BL Direct - All 12 versions
CW Kopp, HP Kopp, S Steiner, S Kriwanek, K … - Obesity, 2003 - nature.com Results: Weight loss significantly reduced circulating plasma TF (314 181 vs.
235 113 pg/mL, p = 0.04), coagulation factor VII (130 22% vs. 113 19%, p =
0.023), and prothrombin fragment F1.2 (2.4 3.4 vs. 1.14 1.1 nM, p = 0.04) ... Cited by 28 - Related articles - BL Direct - All 3 versions
J de Jager, JM Dekker, A Kooy, PJ Kostense, … - Arteriosclerosis Thrombosis and Vascular Biology, 2006 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams &
Wilkins, a division of Wolters ... Explain Much of the Excess ... Cited by 28 - Related articles - All 9 versions
I Palomo, M Alarcon, R Moore-Carrasco, JM … - International journal of molecular medicine, 2006 - dspace.utalca.cl Abstract. Metabolic syndrome (MS) is characterized by the presence of at least
three of the following alterations: enlargement of the waist diameter, higher
levels of arterial pressure, low density lipoprotein cholesterol and ... Cited by 24 - Related articles - View as HTML - BL Direct - All 7 versions
D Prabhakaran, SS Anand - Vascular Medicine, 2004 - vmj.sagepub.com Abstract: The common clustering of glucose intolerance, insulin resistance,
abdominal adipos- ity, elevated blood pressure, and low HDL cholesterol is
referred to as metabolic syndrome. Indi- viduals with this syndrome have an ... Cited by 20 - Related articles - BL Direct - All 3 versions
